ארכיון
ESC hypertension guidelines, what is new?
מערכת האתר 9:43 סגור לתגובות על ESC hypertension guidelines, what is new?
Session 4: IHS ISAjoint session
מערכת האתר 9:40 סגור לתגובות על Session 4: IHS ISAjoint session
Chairpersons: Alon Eisen & Barak Zafrir
Key note: Implementation research: The state of current management of the heightened risk for ASCVD events in a cohort of patients with lupus erythematosus
מערכת האתר 17:22 סגור לתגובות על Key note: Implementation research: The state of current management of the heightened risk for ASCVD events in a cohort of patients with lupus erythematosus
The residual risk of ASCVD patient – what else can be done?
מערכת האתר 17:19 סגור לתגובות על The residual risk of ASCVD patient – what else can be done?
Key note: Regression of atherosclerosis: many approaches to achieve the same goal
מערכת האתר 17:13 סגור לתגובות על Key note: Regression of atherosclerosis: many approaches to achieve the same goal
Dynamic life style-induced changes in Asymmetric Dimethylarginine (ADMA) correlate with alteration in lipid profile and fasting insulin in subjects with the metabolic syndrome
מערכת האתר 17:10 סגור לתגובות על Dynamic life style-induced changes in Asymmetric Dimethylarginine (ADMA) correlate with alteration in lipid profile and fasting insulin in subjects with the metabolic syndrome
Session 3: Non-conventional drivers and protectors of atherosclerosis
מערכת האתר 17:08 סגור לתגובות על Session 3: Non-conventional drivers and protectors of atherosclerosis
Chairpersons: Yehuda Kamari & Ed Fisher
Sustained LDL-C reduction in ASCVD, from long-term trials to real world implementation
מערכת האתר 17:06 סגור לתגובות על Sustained LDL-C reduction in ASCVD, from long-term trials to real world implementation
Key note: The PCSK9 content in platelets of HeFH patients. Role in platelet functionality and the effect of anti-PCSK9 mAbs
מערכת האתר 17:04 סגור לתגובות על Key note: The PCSK9 content in platelets of HeFH patients. Role in platelet functionality and the effect of anti-PCSK9 mAbs
